Attached files
| file | filename |
|---|---|
| EX-3.2 - AMENDED AND RESTATED BY-LAWS OF CVS CAREMARK CORPORATION - CVS HEALTH Corp | dex32.htm |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): December 29, 2010
CVS CAREMARK CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-01011 | 05-0494040 | |
| (Commission File Number) | (IRS Employer Identification No.) | |
| One CVS Drive Woonsocket, Rhode Island |
02895 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Registrant’s telephone number, including area code: (401) 765-1500
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 5 - Corporate Governance and Management
Item 5.03 Amendments to Articles of Incorporation or By-laws; Change in Fiscal Year
On December 29, 2010, CVS Caremark Corporation (the “Company”) filed the attached corrected version of the amended and restated by-laws (the “By-laws”) of the Company (as of May 12, 2010), clarifying certain section cross-reference numbers contained therein.
The foregoing description of the By-laws does not purport to be complete and is qualified in its entirety by reference to the By-laws, and a copy of the Company’s Amended and Restated By-laws effective as of May 12, 2010, reflecting the aforementioned corrections, is attached hereto as Exhibit 3.2 and incorporated by reference herein.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
| (d) | Exhibits |
| Exhibit |
Document | |
| 3.2 | Amended and Restated By-laws of CVS Caremark Corporation | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CVS CAREMARK CORPORATION | ||||||||
| Date: December 29, 2010 | By: | /s/ David M. Denton | ||||||
| Name: | David M. Denton | |||||||
| Title: | Executive Vice President & Chief Financial Officer | |||||||
EXHIBIT INDEX
| Exhibit |
Document | |
| 3.2 | Amended and Restated By-laws of CVS Caremark Corporation | |